Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 03/31/2021 (updated monthly) $1,449.4 (M)
Net Assets - Class A As of 03/31/2021 (updated monthly) $1,159.1 (M)

Positions As of 03/31/2021

Equity VS. NASDAQ Biotechnology Index

Fund Benchmark
Market CapitalizationAs of 03/31/2021 (updated monthly) $26,562.20(M) $39,308.48(M)
P/B RatioAs of 03/31/2021 (updated monthly) 5.13 5.80
P/E Ratio (12-mo Forward)As of 03/31/2021 (updated monthly) 13.39 13.36
Price to Cash FlowAs of 03/31/2021 (updated monthly) 16.08 15.78

Portfolio Details

Asset AllocationAs of 03/31/2021

[name] [value]
Equity 97.75%
Cash & Cash Equivalents 2.25%

Geographic BreakdownAs of 03/31/2021

[name] [value]
United States 91.53%
Cash & Cash Equivalents 2.25%
Denmark 1.98%
Canada 1.92%
Switzerland 1.10%
Netherlands 1.08%
United Kingdom 0.14%

sector breakdownAs of 03/31/2021

[name] [value]
Biotechnology 76.87%
Pharmaceuticals 14.81%
Life Sciences Tools & Services 4.00%
Cash & Cash Equivalents 2.25%
Diversified Capital Markets 1.59%
Other Diversified Financial Services 0.35%
Health Care Facilities 0.14%

TOP TEN HOLDINGSAs of 03/31/2021

Issuer Country Industry % of total
GILEAD SCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.19%
AMGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.47%
REGENERON PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.51%
VERTEX PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.15%
ILLUMINA INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.00%
HORIZON PHARMA PLC United States Pharmaceuticals, Biotechnology & Life Sciences 3.47%
BIOGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.28%
IOVANCE BIOTHERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.05%
NOVAVAX INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.02%
PTC THERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.61%

Market Capitalization BreakdownAs of 03/31/2021

[name] [value]
<2.0 Billion 25.60%
2.0-5.0 Billion 17.55%
5.0-10.0 Billion 15.46%
10.0-25.0 Billion 8.86%
25.0-50.0 Billion 5.65%
>50.0 Billion 25.76%
N/A 1.11%